The intrinsic factor of cell senescence, PCBP2, was identified by unlabeled quantitative proteomics, and its biological role in in vitro replication senescence of human bone marrow mesenchymal stromal ...

In a study published in Nature Communications, researchers at the Beijing Institute of Stem Cells and Regeneration (BISCRM) ...

A novel stem cell therapy demonstrated potential in restoring the corneal surface in patients with blinding corneal injuries.

Your cornea, the eye’s outermost layer, is vital for clear vision. It relies on a steady supply of limbal epithelial stem ...

Peripheral T-cell lymphomas are a rare and heterogeneous type of lymphoma, with geographical and ethnic variations in histological subtypes that differ across the world.1 In The Lancet Haematology, ...

Phase 1 Dose Expansion Initiated for FT819 Off-the-Shelf CAR T-cell Product Candidate with Fludarabine-free Conditioning in ...

USA: A clinical study has demonstrated that transplanted autologous corneal stem cells effectively repaired irreversible ...

ADIA Nutrition Inc. (OTC Pink: ADIA), a frontrunner in health and wellness innovation, is fortifying its brand legacy by filing trademark applications ...

Strategic initiative to address Ukraine’s urgent need for radiation countermeasures Hemafund's infrastructure ensures secure storage and rapid ...

An experimental stem cell therapy reversed corneal damage in half of the participants from a recent clinical trial.

Researchers are exploring multiple approaches to protect transplanted cells from the immune system.

Advances in stem cell biology and immune cell engineering bring diabetes cell therapies closer to reality.